Products / Services
  • Products / Services
  • Companies
  • Buy Leads
    Post Buy Requirement

    Diabetic Care Capsules

    • Supply TypeManufacturer, Supplier, Retailer
    • Preferred Buyer Location All over the world

    Diabetic care caps contains Gymnema sylvestre, which is a tropical herb originating in southern India, has been used for thousands of years to treat type 2 diabetes and several other medical....
    View More Details
    Send Enquiry

    Company Information

    • calendar Member Since 16 Years
    • building Nature of Business Retailer
    • Year of Establishment 2006

    Ask for more detail from the seller

    Contact Supplier
    Report incorrect details
    • Product Details

    • Company Details

    no_img_icon

    Diabetic care caps contains Gymnema sylvestre, which is a tropical herb originating in southern India, has been used for thousands of years to treat type 2 diabetes and several other medical conditions. Today, practitioners of Ayurvedic traditional medicine recommend gymnema as a treatment for high blood sugar, diabetes, high cholesterol, inflammation and obesity. Gymnema is generally regarded as safe and associated with few side effects or drug interactions.
    Diabetic patients were orally administered 1 gram of gymnema extract daily for 60 days. The herb induced increases in circulating insulin and C-peptide which produced reductions in fasting and post-prandial glucose. Also, in vitro measurements of human cells demonstrated direct stimulatory effects of insulin secretion. Neuroprotective effects of Gymnema sylvestre on streptozotocin-induced diabetic neuropathy in rats. The results demonstrated that the brain cell protective effect of Gs may be associated with the inhibitory effect on the excessive activation of inflammatory molecules and oxidative stress mediators.
    Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. The effectiveness of these capsules are derived from an extract from the leaves of Gymnema sylvestre, in controlling hyperglycaemia  Type 2 diabetic patients on conventional oral anti-hyperglycaemic agents. Gymnema (400 mg/day) was administered for 18-20 months as a supplement to the conventional oral drugs. During supplementation, the patients showed a significant reduction in blood glucose, glycosylated haemoglobin and glycosylated plasma proteins, and conventional drug dosage could be decreased. Most of the diabetic patients were able to discontinue their conventional drug and maintain their blood glucose homeostasis with Gymnema alone. These data suggest that the beta cells may be regenerated/repaired in Type 2 diabetic patients with supplementation. This is supported by the appearance of raised insulin levels in the serum of patients after supplementation.


    Share your requirements for a quick response!
    Tell us what you need?

    By clicking Get Quotes Now, I accept the T&C and Privacy Policy.

    Looking for Diabetic Care Capsules?

    Quantity
    Seller Contact Details
    • SellerTVS BIOTECH
    • Address Annathanapatti, Salem, Tamil Nadu
    Waiting for permission
    To search by voice, go to your browser settings and allow access to microphone

    Allow microphone access to search with voice